Molnupiravir not included in COVID-19 treatment guidelines as its harms outweigh benefits: ICMR

Noting its rampant and irrational use of the pill, Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) said that efforts should be made to restrict its use.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fgsAKv
via IFTTT